Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsRaw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tg Therapeutics (TGTX) Retained Earnings: 2016-2024

Historic Retained Earnings for Tg Therapeutics (TGTX) over the last 9 years, with Dec 2024 value amounting to -$1.5 billion.

  • Tg Therapeutics' Retained Earnings rose 30.93% to -$1.1 billion in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.1 billion, marking a year-over-year increase of 30.93%. This contributed to the annual value of -$1.5 billion for FY2024, which is 1.51% up from last year.
  • As of FY2024, Tg Therapeutics' Retained Earnings stood at -$1.5 billion, which was up 1.51% from -$1.6 billion recorded in FY2023.
  • In the past 5 years, Tg Therapeutics' Retained Earnings registered a high of -$980.6 million during FY2020, and its lowest value of -$1.6 billion during FY2023.
  • Moreover, its 3-year median value for Retained Earnings was -$1.5 billion (2024), whereas its average is -$1.5 billion.
  • Per our database at Business Quant, Tg Therapeutics' Retained Earnings tumbled by 39.84% in 2020 and then increased by 1.51% in 2024.
  • Over the past 5 years, Tg Therapeutics' Retained Earnings (Yearly) stood at -$980.6 million in 2020, then crashed by 35.50% to -$1.3 billion in 2021, then dropped by 14.93% to -$1.5 billion in 2022, then dropped by 1.67% to -$1.6 billion in 2023, then increased by 1.51% to -$1.5 billion in 2024.